Theseus Pharmaceuticals Statistics
Total Valuation
TASCOM has a market cap or net worth of KRW 19.37 billion.
Market Cap | 19.37B |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
TASCOM has 4.68 million shares outstanding.
Current Share Class | 4.68M |
Shares Outstanding | 4.68M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 60.18% |
Owned by Institutions (%) | 57.15% |
Float | 1.80M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3.50 |
PB Ratio | 5.84 |
P/TBV Ratio | 8.97 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.52, with a Debt / Equity ratio of 0.17.
Current Ratio | 1.52 |
Quick Ratio | 1.01 |
Debt / Equity | 0.17 |
Debt / EBITDA | n/a |
Debt / FCF | -0.35 |
Interest Coverage | -31.70 |
Financial Efficiency
Return on equity (ROE) is -57.90% and return on invested capital (ROIC) is -28.38%.
Return on Equity (ROE) | -57.90% |
Return on Assets (ROA) | -17.75% |
Return on Invested Capital (ROIC) | -28.38% |
Return on Capital Employed (ROCE) | -47.30% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.90 |
Inventory Turnover | 5.28 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.94% in the last 52 weeks. The beta is 0.12, so TASCOM's price volatility has been lower than the market average.
Beta (5Y) | 0.12 |
52-Week Price Change | -52.94% |
50-Day Moving Average | 4,192.80 |
200-Day Moving Average | 4,157.28 |
Relative Strength Index (RSI) | 45.73 |
Average Volume (20 Days) | 44 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TASCOM had revenue of KRW 5.53 billion and -1.74 billion in losses. Loss per share was -824.00.
Revenue | 5.53B |
Gross Profit | 158.89M |
Operating Income | -1.75B |
Pretax Income | -1.74B |
Net Income | -1.74B |
EBITDA | -1.21B |
EBIT | -1.75B |
Loss Per Share | -824.00 |
Balance Sheet
The company has 886.47 million in cash and 553.57 million in debt, giving a net cash position of 332.89 million or 71.06 per share.
Cash & Cash Equivalents | 886.47M |
Total Debt | 553.57M |
Net Cash | 332.89M |
Net Cash Per Share | 71.06 |
Equity (Book Value) | 3.32B |
Book Value Per Share | 1,429.67 |
Working Capital | 1.98B |
Cash Flow
In the last 12 months, operating cash flow was -1.35 billion and capital expenditures -232.08 million, giving a free cash flow of -1.58 billion.
Operating Cash Flow | -1.35B |
Capital Expenditures | -232.08M |
Free Cash Flow | -1.58B |
FCF Per Share | -337.39 |
Margins
Gross margin is 2.87%, with operating and profit margins of -31.58% and -31.47%.
Gross Margin | 2.87% |
Operating Margin | -31.58% |
Pretax Margin | -31.47% |
Profit Margin | -31.47% |
EBITDA Margin | -21.88% |
EBIT Margin | -31.58% |
FCF Margin | n/a |
Dividends & Yields
TASCOM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -111.25% |
Shareholder Yield | n/a |
Earnings Yield | -8.99% |
FCF Yield | -8.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TASCOM has an Altman Z-Score of -0.7 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.7 |
Piotroski F-Score | 2 |